Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2

B and T lymphocyte attenuator (BTLA) is an immune checkpoint molecule that mediates the escape of tumor cells from immunosurveillance. Consequently, BTLA and its ligand herpesvirus entry mediator (HVEM) are potentially immunotherapeutic targets. However, the potential effects of BTLA on tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tian-You, Liu, Ya-Juan, Yan, Hong, Xi, Yi-Bo, Duan, Li-Qiang, Wang, Yang, Zhang, Tian-Tian, Gu, Yin-Min, Wang, Xiao-Dong, Wu, Chang-Xin, Gao, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777428/
https://www.ncbi.nlm.nih.gov/pubmed/36552785
http://dx.doi.org/10.3390/cells11244021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777428/
https://www.ncbi.nlm.nih.gov/pubmed/36552785
http://dx.doi.org/10.3390/cells11244021

Ejemplares similares